NCT03864783View on ClinicalTrials.gov

The Effect of Curcumin on Liver Fat Content in Obese Subjects

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

December 16, 2020

Study Completion Date

December 16, 2020

Conditions
Non-Alcoholic Fatty Liver DiseaseInsulin ResistanceGlucose Tolerance ImpairedObesity, Abdominal
Interventions
DIETARY_SUPPLEMENT

Curcumin (Meriva®)

"Experimental drug:~Meriva® 500 mg tablet (contains 1 mg curcumin)"

DRUG

Placebo Oral Tablet

"Placebo:~Contains same ingredients as Meriva®, apart from curcumin. Similar in appearance to Meriva®."

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Hellerup

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

collaborator

University of Aarhus

OTHER

collaborator

Herlev and Gentofte Hospital

OTHER

lead

Steno Diabetes Center Copenhagen

OTHER

NCT03864783 - The Effect of Curcumin on Liver Fat Content in Obese Subjects | Biotech Hunter | Biotech Hunter